NCI is moving forward with a plan to evaluate multi-cancer early detection tests, a technology that is rapidly making inroads into the healthcare system.
The NCI Board of Scientific Advisors unanimously approved eight new concepts and nine reissued concepts at a meeting June 13-15.
Alex A. Adjei was named chair of Cleveland Clinic Taussig Cancer Institute. He succeeds Jame Abraham, who has been interim chair of Taussig Cancer Institute since May 2021.
Joe W. Ramos was named director of the Louisiana Cancer Research Center.
McKesson Corp. and HCA Healthcare Inc. announced an agreement to combine McKesson’s US Oncology Research and HCA Healthcare’s Sarah Cannon Research Institute.
The Richard K. Lubin Family Foundation will provide a grant to establish the Lubin Family Foundation Scholar Awards at Dana-Farber Cancer Institute.
Photo credit: TANGRYSTAN, BrystkreftforeningenThe world’s first statue of a woman with incurable breast cancer—Cecilie, a 44-year-old mother of three—was unveiled at Eidsvoll Square, in front of Stortinget, the Norwegian Parliament, on June 20.
Texas Oncology broke ground on a 32,000-square foot cancer care center located on the CHRISTUS Southeast Texas St. Elizabeth hospital campus.
For the past several years, interest in FLASH radiation therapy research has surged in the oncology community.1 It is arguably one of the hottest topics in cancer care today, with the potential to shift the trajectory of treatment in ways that were once only imaginable.
A report led by researchers at the American Cancer Society, in collaboration with NCI, showed that more than 18 million Americans (8.3 million males and 9.7 million females) with a history of cancer were living in the United States as of Jan. 1, 2022, with over 12 million (67%) aged 65 years or older.
